Navigation Links
Sinovac Reports Unaudited First Quarter 2012 Financial Results
Date:5/15/2012

ast year.  The major driver of the higher operating expense was the increase in research and development expenses as the Company advances its pipeline vaccine candidates.

The Company's operating loss was $8.2 million for the first quarter 2012, compared to $3.5 million for the first quarter last year.

Loss before income taxes and non-controlling interests was $7.7 million, compared to $3.4 million in the same quarter last year.

Net loss attributable to stockholders in the first quarter 2012 was $5.6 million, or $0.10 per basic and diluted share, compared to a net loss of $2.8 million, or $0.05 per basic and diluted share, for the same quarter last year.

As of March 31, 2012, cash and cash equivalents totaled $94.5 million, compared to $104.3 million as of December 31, 2011. During the first quarter of 2012, the Company utilized $3.1 million of its cash resources to contribute to its ongoing clinical trial for its proprietary EV71 vaccine.  The Company intends to provide the trial with approximately additional $7 million during the remaining quarters of the year. Under the credit line arrangements already in place that cover the ongoing capital needs of the Changping site development, $2.2 million was utilized in the first quarter.  Capital expenditure payments to complete the Changping site, which are covered by the same credit line arrangements, are estimated to be around $20 million in the remaining quarters of 2012 and $1.7 million in 2013. Conference Call DetailsThe Company will host a conference call on Tuesday, May 15, 2012 at 8:00 a.m. EDT (May 15, 2012 at 8:00 p.m. China Standard Time) to review the Company's financial results and provide an update on recent corporate developments.  To access the conference call, please dial 1-877-407-4018 (USA) or 1-201-689-8471 (International).  A replay of the call will be available from 11 a.m. EDT on May 15, 2012 to May 29, 2012 at midnight.  To access the
'/>"/>

SOURCE Sinovac Biotech Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Sinovac to Host Conference Call to Report First Quarter 2012 Unaudited Financial Results
2. Sinovac to Host Conference Call to Report Fourth Quarter 2011 Unaudited Financial Results
3. Sinovac Receives Nasdaq Deficiency Letter Regarding Audit Committee Requirement
4. Sinovac to Present at 23rd Annual Piper Jaffray Health Care Conference and HK/China Mini Conference 2011 (Healthcare)
5. /C O R R E C T I O N -- Sinovac Biotech Ltd./
6. Sinovac Reports Unaudited Third Quarter 2011 Financial Results
7. Sinovac Reports Positive Preliminary Phase II Clinical Trial Results for EV71 Vaccine Against Hand, Foot and Mouth Disease
8. Sinovac to Host Conference Call to Report Third Quarter 2011 Unaudited Financial Results
9. Sinovac Reports Unaudited Second Quarter 2011 Financial Results
10. Sinovac Announces Management Changes
11. Sinovac Holds 2011 Annual Shareholders Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Calif. , Nov. 26, 2014  Genomic Health, ... Kim Popovits , Chairman, Chief Executive Officer and President, ... Jaffray Healthcare Conference at The New York Palace Hotel ... December 3 at 11:30 am Eastern Time (ET). ... of the conference call, go to the  Investor Relations ...
(Date:11/26/2014)... , Nov. 26, 2014  Over 100 million ... those suffer from this pain daily. Chronic and acute ... pain management is born to fulfill the need for ... types of pain. On October 28th, a ... Cumberland, Maryland community.  This new ...
(Date:11/26/2014)... Oregon , November 26, 2014 ... fascia of the organ protrudes through the wall of a ... muscle area at birth are some of the causes of ... umbilical, hiatal, femoral, and incisional. An inguinal hernia is when ... An umbilical hernia is found in the area of the ...
Breaking Medicine Technology:Genomic Health to Present at the 26th Annual Piper Jaffray Healthcare Conference 2Genomic Health to Present at the 26th Annual Piper Jaffray Healthcare Conference 3New Pain Management Center Opens in Cumberland, Md. 2Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 2Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 3Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 4
... IRVINE, Calif., Feb. 15, 2011 Endologix, Inc. (Nasdaq: ... for aortic disorders, announced today the presentation of the ... 2011 iCON (International Congress of Endovascular Specialists) annual meeting ... Roll-In phase of the trial, technical success rates of ...
... 15, 2011 Daiichi Sankyo, Inc. (DSI), today announced ... Bethlehem Township, Pennsylvania from Amcor, a global packaging manufacturer. ... resources to more cost-effectively supplement its operations rather than ... be operational in the summer or early fall of ...
Cached Medicine Technology:Endologix Announces Presentation of Favorable Initial PEVAR Trial Results 2Endologix Announces Presentation of Favorable Initial PEVAR Trial Results 3Daiichi Sankyo, Inc. Acquires First US-Based Packaging and Manufacturing Facility 2
(Date:11/28/2014)... CA (PRWEB) November 28, 2014 ... on December 2, 2014. This national movement was created ... communities by giving to local charities and causes. ... Holiday, coincides with the kickoff of the holiday shopping ... is to shopping and Cyber Monday is to online ...
(Date:11/28/2014)... November 28, 2014 Dr. Diane Walder, ... , announced the addition of Dr. Bridgit Nolan to ... the practice after having completed her dermatology residency at ... Dr. Walder invited Dr. Nolan to join ... surgery and cosmetic dermatology. Not only does Dr. Nolan ...
(Date:11/28/2014)... Dr. Diane Walder, one of South Florida’s top ... practice called Ultrashape that is designed to help her patients ... six weeks. Ultrashape has been praised by patients as being ... compared to other types of external fat reduction. , “If ... Walder. , According to Dr. Walder, Ultrashape works by ...
(Date:11/28/2014)... Written and narrated by award winning author Dr. James ... Happiest Man In the World: Life Lessons From a Cultural ... Project C.U.R.E. came to be. , Raised in the Boise ... Richard W. Jackson, Dr. Jackson exceeded his goal of being ... he wasn’t happy. Prompted by this realization, James and his ...
(Date:11/28/2014)... (PRWEB) November 28, 2014 ... testing and treatment, helped employees learn their risk ... diabetes blood screening at a local school in ... @ Work initiative. , As the Presenting ... program , PreDiabetes Centers is co-hosting diabetes-prevention presentations ...
Breaking Medicine News(10 mins):Health News:Pathways Home Health & Hospice Joins #GivingTuesday; Annual Holiday Encourages Local Charitable Giving 2Health News:Pathways Home Health & Hospice Joins #GivingTuesday; Annual Holiday Encourages Local Charitable Giving 3Health News:Dr. Diane Walder Welcomes New Cosmetic Dermatologist to Practice 2Health News:Dr. Diane Walder Introduces New Fat Reduction Treatment Called Ultrashape 2Health News:Dr. Diane Walder Introduces New Fat Reduction Treatment Called Ultrashape 3Health News:Thanksgiving Weekend Audiobook Treat! “The Happiest Man In the World: Life Lessons From a Cultural Economist” by Dr. James W. Jackson 2Health News:PreDiabetes Centers Offers Workplace Diabetes Screening at Local School 2
... are testing a cancer-fighting film that could be applied ... which can be made into any size and shape, ... tumor site as it dissolves over several weeks. This ... ,A paper-thin, biodegradable implant is proving ...
... Biology online on February 8, have developed a small-molecule ... the control of cell division. The researchers show that ... mice and cancer-derived cells growing in culture. ... by two collaborating groups—one (Lenart et al.) led by ...
... to formulate rules on organ donations to foreigners. This ... ,Mr.Mundo emphasized on the need for such guidelines as ... flourishing in the country especially among the poorer sections of ... to set forth a list of guidelines has become necessary ...
... in the journal Blood, allogeneic stem cell transplants are ... ,An allogeneic stem cell transplant is a ... and lymphoma. The process of an allogeneic stem cell ... total body irradiation. These treatment approaches tend to kill ...
... therapy device may help people regain strength and normal ... to a University of California, Irvine study. ... ability to grasp and release objects after therapy sessions ... had at least moderate residual weakness and reduced function ...
... key inflammatory mediators (IL-12 and IL-23) is highly effective//, ... ,Current treatments for psoriasis include topical ... of the disease. Many of these treatments are messy, ... effective, according to Gerald Krueger, M.D., principal investigator for ...
Cached Medicine News:Health News:A Better Way to Deliver Cancer Drugs 2Health News:New Protein Inhibitor Halts Growth Of Cancerous Cells 2Health News:Allogeneic Stem Cell Transplants Linked With Risk for Diabetes and Hypertension 2Health News:Robotic Therapy Helps Restore Hand Use After Stroke 2Health News:Robotic Therapy Helps Restore Hand Use After Stroke 3Health News:New Treatment For Psoriasis Is Highly Effective 2
... Cobas Integra 400 plus, innovation means ... of reaction cuvettes and im-proved operator ... menu and ease-of-use required for true ... only possible with only one analytical ...
... The Advia 1650 has ... (as low as 2 L/test), ... 80 L/test) and water consumption ... management efficiency. Optional universal rack ...
Iron UIBC (UIBC Buffer + Color + Std.). An Automated analyzer test kits....
HDL Cholesterol, liquid....
Medicine Products: